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Summary: Antiepileptic drugs (AEDs) vary in their effi- 
cacy against generalized tonic-clonic, myoclonic, and a b  
sence seizures, suggesting different mechanisms of action. 
Phenytoin (PHT), carbamazepine (CBZ), and valproate 
(VPA) reduced the ability of mouse central neurons to sus- 
tain high-frequency repetitive firing of action potentials 
(SRF) at therapeutic free serum concentrations. Phenobar- 
bital (PB) and the benzodiazepines (BZDs), diazepam 
(DZP), clonazepam (CZP), and lorazepam (UP), also re- 
duced SRF, but only at supratherapeutic free serum con- 
centrations achieved in treatment of generalized tonic- 
clonic status epilepticus. These AEDs interact with sodium 
channels to slow the rate of recovery of the channels from 
inactivation. The BZDs and PB enhanced 7-aminobutyric 
acid (GABA) responses evoked on mouse central neurons 
by binding to two different sites on the GABA,, receptor 
channel. BZDs increased the frequency of GABA receptor 
channel openings. In contrast, barbiturates increased the 
open duration of these channels. VPA enhanced brain 
GABA concentration and may enhance release of GABA 
from nerve terminals. Ethosuximide (ESM) reduced a 
small transient calcium current which has been shown to be 
involved in slow rhythmic firing of certain neurons. Re- 
duction of SRF, enhancement of GABA-ergic inhibition, 
and reduction of calcium current may be, in part, the bases 
for AED action against generalized tonic-clonic, myo- 
clonic, and absence seizures, respectively. Key Words: An- 
ticonvulsants-Neuropharmacology-Membrane poten- 
tials-Calcium. 
Despite substantial interest in developing safer and 
more efficacious antiepileptic drugs (AEDs), six 
classes of AEDs, which have been in use for 15-75 
years, continue to be the primary drugs used to treat 
patients with epilepsy. The AED classes are hydan- 
toins [phenytoin (PHT)], iminostilbenes [carbamaze- 
pine (CBZ)], barbiturates [phenobarbital (PB), pri- 
midone (PRM)], fatty acids [valproate (VPA)], 
benzodiazepines (BZDs) [clonazepam (CZP), diaze- 
pam (DZP), nitrazepam (NZP), lorazepam (LZP)], 
and succinimides [ethosuximide (ESM)]. These 
AEDs are used to treat generalized tonic-clonic, 
myoclonic, absence, and partial seizures. Multiple 
classes of AED have been used because of variable 
selectivity against the epilepsies (Table 1). PHT and 
CBZ are administered exclusively for generalized 
tonic-clonic and partial seizures, whereas ESM is 
used exclusively against generalized absence seizures. 
VPA, barbiturates, and BZDs have a broader range of 
action, but drugs from the latter two classes have use 
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limited by sedation and development of tolerance. 
The different selectivity of the AEDs suggests multi- 
ple mechanisms of action. 
Consistent with this view, several neuronal proper- 
ties have been shown to be regulated by AEDs (Mac- 
donald and McLean, 1986). AEDs reduce sustained, 
high-frequency, repetitive firing of action potentials 
(SRF), enhance GABAergic inhibition, and reduce 
calcium currents. In the sections below, these three 
mechanisms will be discussed. 
EFFECI'S OF AEDs ON SRF 
AEDs have been shown to alter many membrane 
properties of neurons and axons (Esplin, 1957; 
Raines and Standaert, 1966; Hershkowitz and 
Raines, 1978; Macdonald and McLean, 1986). How- 
ever, to be an AED mechanism of action, the mem- 
brane effects must be produced at CSF and plasma 
concentrations free of protein binding in ambulatory 
patients. A direct membrane effect produced only at 
toxic free-plasma levels is unlikely to be a relevant 
AED mechanism of action. PHT, CBZ, VPA, antiep 
ileptic BZDs, PB, and PRM blocked SRF in verte- 
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TABLE 1. Different effectiveness of AEDs 
against the euileusies 
TABLE 2. Effects of clinically used AEDs 
on sodium channel functiona 
GTCS/PS MCS GAS 
- - PHT ++ 
CBZ ++ 
VPA ++ ++ ++ 
PB + + 
CZP + ++ + 
ESM - - ++ 
- - 
- 
PHT = phenytoin; CBZ = carbamazepine; VPA = valproate; PB 
= phenobarbital; CZP = clonazepam; ESM = ethosuximide; 
GTCS = generalized tonic-clonic seizures; PS = partial seizures; 
MCS = myoclonic seizures; GAS = generalized absence seizures. 
++ = Efficacy against the seizure type at nontoxic serum con- 
centrations. + = Efficacy against the seizure type at toxic concentrations. 
- -  - NO efficacy. 
brate cortical and spinal cord neurons in cell culture 
(McLean and Macdonald, 1983; Macdonald and 
McLean, 1986). However, only PHT, CBZ, and VPA 
reduced SRF (Fig. 1) at therapeutic free-serum con- 
centrations (Table 2). 
The AED-induced block of SRF has several im- 
portant properties. First, the block is voltagedepen- 
dent. Reduction of SRF by AEDs can be reversed by 
CONT VPA 12pM 
L ’ 0.8 
0.1 nA 
Em -65mV 














Several AEDs reduced sustained, high-frequency, repetitive fir- 
ing of action potentials by interacting with sodium conductance 
(gNa). It is likely that this action was to enhance sodium-channel 
inactivation. 
++ = Effect of AED on sodium-channel function (gNa) at thera- 
peutic free-serum concentrations. + = Effect on sodium-channel function at toxic concentrations. 
- -  - No effect. 
CONC = concentrations above which the AEDs modify so- 
dium-channel function. 
R. = minimum therapeutic free-serum concentrations against 
generalized tonic-clonic and partial seizures. 
Other drug abbreviations as in Table I. 
maintained membrane hyperpolarization and in- 
creased by maintained membrane depolarization. 
Second, the effect of the AEDs is usedependent. Fol- 
lowing membrane depolarization, most neurons fire 
a train of action potentials with varying degrees of 
PHT 81cM CBZ 8.5uM 
-62  mV 
%T- 




FIG. 1. Valproate (VPA), phenytoin (PHT). and carbamazepine (CBZ) limited sustained, high-frequency, repetitive firing of a c t i  poten- 
tials (SRF). lntracellular recordings were made from spinal cord neurons in cell culture, and increasing depolarizingcunent pulses (EM) were 
applied. Magnitude of the current pulses is shown below each of the traces in nanoamps. The membrane potentials from which the 
depolarizing pulses were applied appear below each column. In control medium (CONT), SRF was obtained through& all ranges of 
depolarization. In the presence of VPA, PHT, and CBZ. limitation of SRF was seen at each of the membrane potentials. (From McLean and 
Macdonakl, 1983,1986e.b.) 
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spike frequency adaptation. However, in the presence 
of an AED, the action potentials within the train are 
progressively altered. The initial action potential is 
unaffected, but each subsequent one has a smaller 
amplitude and a lower rate of rise. Eventually, firing 
of action potentials fails during the depolarization. 
Third, the effect of the AEDs is time dependent. After 
SRF has been blocked, single evoked action poten- 
tials will have reduced the amplitude and the rate of 
rise for several hundred msec. Thus, removing the 
effect of the AED takes several hundred ms. 
PHT and CBZ reduced the amplitude of sodium- 
dependent action potentials by increasing the voltage 
dependency of steady-state inactivation and by re- 
ducing the rate of recovery of sodium channels from 
inactivation (Courtney and Etter, 1983; McLean and 
Macdonald, 1983; Matsuki et al., 1984; Willow et al., 
1985; McLean and Macdonald, 1986b). PHT, CBZ, 
PB, and DZP all inhibited the binding of [HJ- 
batrachotoxin A 20-a-benzoate (BTX-B) to sodium 
channels and reduced batrachotoxin-stimulated 22Na 
influx in brain synaptic terminals (Willow et al., 
1984). BTX-B is a toxin that binds to sodium chan- 
nels at a site related to activation of sodium channel 
ion flux (Willow and Catterall, 1982). 
The effects of the AEDs on sodium channels are 
similar to those of local anesthetic drugs (Strichartz, 
1973; Courtney, 1975; Hille, 1977; Khodorov, 1981). 
The action of these drugs has been interpreted using 
the modulated-receptor hypothesis (Hille, 1977; 
Courtney and Etter, 1983). The sodium channel has 
been demonstrated to exist in three main conforma- 
tions: a resting (R) or activatable state, an open (0) or 
conducting state, and an inactive (I) or nonactivat- 
able state (Fig. 2). Under normal circumstances, 
when membrane potential is large and negative, most 
of the sodium channels are in the activatable state. 
Upon membrane depolarization, a large number of 
p - f i 7 f D  
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FIG. 2. Vdtageactivated sodium channels have three main 
states: rest (R). open (0). 01 inactivated (I). The distribution of 
channels among these states in agiven newon is a function of 
rnembrenepotential andtime. When alocalamstheW . OT AED (0) 
binds to the channel (DR. DO. DI). the dmbution of channels 
among states may change, and the transition rates between 
states may change. (See text for further discussion.) 
the sodium channels open, depending upon the level 
of the membrane depolarization. With progressive 
depolarization, some channels are converted to the 
inactive state; membrane depolarization now will 
open fewer channels. If the membrane is strongly de- 
polarized, all channels may be in the inactive state, 
and no channels will open. To remove channel inac- 
tivation, the membrane must be hyperpolarized 
again to a large negative voltage. 
The modulated-receptor hypothesis postulates that 
drugs bind to the different forms of these channels 
with Merent affinity. The AEDs likely bind to the 
inactive form of the channel (Fig. 2). Therefore, when 
a neuron has a large negative membrane potential, all 
the channels are closed and are not bound with high 
affinity by the AEDs. In contrast, when the cell is 
depolarized, a fraction of the channels are inactive, 
allowing equilibrium to shift toward the bound, inae 
tive conformation of the channel. In such a model, 
AEDs can produce t ime ,  voltage-, and usedepen- 
dent block of sodium-dependent action potentials 
because the fraction of inactive channels is increased 
by membrane depolarization and by mpetitive firing. 
Since the drug that is bound to the inactive channels 
takes time to dissociate, the block is time dependent. 
Therefore, it is likely that AEDs block SRF of sodium 
action potentials by selectively binding to the inactive 
form of the sodium channel. 
While the apparent mechanism of action of VPA is 
similar to that of PHT and CBZ (McLean and Ma0 
donald, 1986a), VPA has not been shown to bind to 
the BTX-B binding site on sodium channels (Willow 
and Catterall, 1982) or to block batrachotoxin-stimu- 
lated 22Na influx in brain synaptic terminals (Willow 
et al., 1984). Thus, VPA may bind to a different Site 
on sodium channels than PHT and CBZ. 
Barbiturates, PRM, and BZDs also block SRF, but 
only at supratherapeutic concentrations (Macdonald 
and McLean, 1986; McLean and Macdonald, 1988). 
However, barbiturates and BZDs block SRF at con- 
centrations that are achieved in the treatment of gen- 
eralized tonic-clonic status epilepticus (Table 2). 
Thus, it is likely that both PB and DZP block SRF at 
concentrations achieved in the treatment of general- 
ized tonic-clonic status epilepticus and that this effm 
may contribute to their antiepileptic action in this 
clinical setting. 
In contrast to PHT, CBZ, VPA, BZDs, PB, and 
PRM, the antiabsence drug ESM did not block SRF 
(Macdonald and McLean, 1986), reduce BTX-B 
binding (Willow and Catterall, 1982), or reduce ba- 
trachotoxin-stimulated "Na influx in brain synaptic 
terminals (Willow et al., 1984). Thus, blockade of 
SRF may be at least partly responsible for preventing 
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FIG. 3. GABA-receptor chloride Currents were enhanced by diazepam (DZP) and phenobarbital (PB). Mouse spinal cord neurons were 
voltage clamped at -75mV using the whdecell recording technique. GABA (2 pM) was applied by pressure ejection from Munt-tipped 
micropipettes p o s i t i i  adjacent to the neuron. A GABA-receptor current (Al) was enhanced when DZP (20 nM) was applied with GABA 
(A2). 8: GABA-receptor current (Bl) was also enhanced when applied to PB (500 pM) (82). The equilibrium potential for chloride ions was 0 
mV; therefore, the GABA-receptor currents were inward (downgoing). (From Twyman e t  al., 1989.) 
generalized tonic-clonic and partial seizures, but not 
generalized absence seizures. 
EFFECTS OF AEDs ON INHIBITORY 
MECHANISMS 
Synaptic inhibition is an important mechanism for 
regulation of central nervous system excitability. En- 
hancement of inhibition, therefore, would be an ef- 
fective way to decrease abnormal excitability. Inhibi- 
tion in the nervous system is mediated by a number 
of neurotransmitters and their corresponding recep- 
tors. Rapid inhibition is mediated primarily by 
amino acid neurotransmitters, including y-aminobu- 
tyric acid (GABA) and glycine acting on postsynaptic 
GABA (GABAA) receptors and glycine receptors, re- 
spectively. Rapid forms of inhibition mediated by 
glycine and GABA receptors are produced by activa- 
tion of neurotransmitter receptors where the proteins 
forming the receptor also form the channel (Gren- 
ningloh et al., 1987; Schofield et al., 1987). 
The only form of inhibition clearly shown to be 
regulated by AEDs is GABAergic inhibition. Both 
barbiturates and BZDs enhance postsynaptic GABA- 
receptor current (Fig. 3). The GABA receptor has 
been shown to be an oligomeric complex consisting 
of at least two binding sites for GABA, allosteric regu- 
latory binding sites for BZDs and j3-carbolines, picro- 
toxin-like convulsant drugs and barbiturates, and a 
chloride channel (Polc et al., 1982; Tallman and Gal- 
lager, 1985; Olsen and Venter, 1986). The receptor 
appears to be formed from two peptide subunits, an 
a-chain and a &chain, with a stoiciometry of a2P2 
(Schofield et al., 1987), and there are at least three 
different isoforms of a-chain (Levitan et al., 1988). 
The GABA binding site is on the &chain, and the 
BZD binding site is on the a-chain. Each peptide 
chain spans the membrane at least four times, having 
four membrane or M regions. The juxtaposition of 
the M regions is thought to form the chloride ion 
channel opened by GABA binding. A series of posi- 
tive charges around the extracellular portion of the M 
regions are presumably involved in regulating the 
negatively charged chloride ion entry and repelling 
the positively charged cations. 
TABLE 3. Variable efectts ofAEDs 
on GABAergic inhibition 
Drug GABA CONC RX 
PHT - - - 
CBZ - - - 
VPA +/? 150.0 pgml >2.5 pglml 
PB + >5.0 pglml >5.0 pgml 
CZP ++ > 1 .O nglml >2.6 nglml 
ESM - - - 
+/? = Questionable enhancement of GABA-receptor current 
+ = Weak enhancement of postsynaptic GABA current at high 
++ = Potent enhancement of postsynaptic GABA-receptor cur- 
due to enhanced release of GABA from presynaptic terminals. 
therapeutic and slightly toxic Serum concentrations. 
rent at therapeutic free-serum concentrations. 
sion. 
GABAergic synaptic transmission. 
myoclonic seizures. 
- -  - No demonstrated effect on GABAergic synaptic transmis- 
CONC = Minimal effective concentrations to enhance 
R, = Threshold free-serum therapeutic concentrations against 
Drug abbreviations as shown in Table I .  
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Barbiturates and BZDs bind to specific allosteric 
regulatory binding sites on the GABA receptor. BZDs 
have been shown to enhance the binding of GABA to 
its receptor (Meiners and Salama, 1982; Skenitt et 
al., 1982) and to enhance GABA-receptor current 
(Choi et al., 1977; Macdonald and Barker, 1978). 
Phenobarbital, however, does not enhance the bind- 
ing of GABA to its receptor (Olsen and Snowman, 
1982) but does enhance GABA-receptor current 
(Macdonald and Barker, 1978). The BZDs DZP, 
CZP, and NZP all enhance GABA-receptor current 
at low nanomolar concentrations that are achieved in 
CSF and plasma unbound to plasma proteins (Sker- 
ritt and Macdonald, 1984) (Table 3). Similarly, PB 
enhances GABA-receptor current at a concentration 
achieved in ambulatory patients in CSF and plasma 
unbound to plasma proteins (Schulz and Macdonald, 
1981) (Table 3). 
While both BZDs and barbiturates enhance 
GABA-receptor current, they do so by different 
mechanisms (Study and Barker, 1981; Twyman et 
al., 1989). When GABA binds to its receptor and 
gates open the chloride ion channel, the channel 
opens and closes rapidly, forming bursts of openings 
interrupted by brief closures (Hamill et al., 1983; 
Macdonald et al., 1989). This bursting behavior of 
GABA-receptor currents appears to be a general 
property of neurotransmitter-gated receptor channels 
(Colquhoun and Sakmann, 1985). BZDs increase the 
frequency of Occurrence of these bursting GABA-re- 
ceptor currents (Bormann, 1988; Twyman et al., 
1988, 1989). Barbiturates, however, do not, but in- 
stead, appear to modify the stability of individual 
openings (Twyman et al., 1988, 1989). The GABA- 
receptor bursts are still present, but the openings 
within the bursts are prolonged, and there is more 
current flow per burst (Fig. 4). Thus, BZDs and barbi- 
turates enhance GABA-receptor currents by binding 
to different sites and by regulating different properties 
of the GABA-receptor channel (Fig. 5). 
In addition to enhancing postsynaptic GABA-re- 
ceptor-channel properties, drugs that intensify the re- 
lease of GABA are thought also to have antiepileptic 
properties. The most notable such drug is VPA. VPA 
has been demonstrated to block GABA catabolism by 
inhibiting succinic simialdehyde dehydrogenase 
(Chapman et al., 1982) and by increasing brain 




GFIBFl2 uM + DlFIZEPFlM 20 nM 
C 
GFIBFI 2 uM + PHENOBFIRBITFIL 500 uM 
FIG. 4. Singlechannel GABA-receptor currents were enhanced by diazepam (DZP) and phenobarktar . (pe). Patches of mouse spinal cad 
neurons were removed using the "outside-out" configuration for patchclamp recordi. GABA was applii to the excised patches by local 
pressure ejection. A: Prior to application of GABA. only rare. brief. spontaneous currents were recwded. CheMal opening produced a 
activity. D In the presence of PB (500 M. GABA again increased GABA-receptor channel activity. Membrane patches wem voltage 
clamped at -75 mV. and chloride equilibrium potential was 0 mV. DZP increased the frequency of charmel opening without altering the 
Twyman et al., 1989.) 
downward deflection of the current recording. B: Fdlowing application of GABA (2 pM). &gb&and auTentSiroeesed infrequencyand 
occurred as single individual openings or in bursts of openings. C In the presance of DZP (20 nM), GABA evoked increased -
basii duration of openings, whereas PB did not increase the frequency of channel openings but prolonged inmidud openings. (From 
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FIG. 5. Barbiturates and benzodiazepines had different sites of action to enhance GABA-receptor current. A GABA (Al) involved 
frequent channel openings in isolation or in bursts. Prolonged bursts are ovemred. In the presence of diazepam (DZP) (A2). bursts with 
staMe long openings were of the same duration but more frequent. This resulted in more GABA-receptor current. In the presence of 
(PB) (A4. bursts were prolonged and consisted of longer singlechannel openings. 6: In a simplified burst kinetic model for 
the GABA-receptor-channel complex, 2 molecules of GABA bind to the receptor to gate open the chloride channel into bursts. DZP 
enhanced GABA binding affinity to increased burst frequency without altering individual GABA-receptor bursts. PB altered the GABA-re- 
-or burrts by prolonging the time spent in the open state. This site of action may be at or near the channel to modify the proparties of 
channel gating. (From Twyman et al., 1989.) 
nal pools (Larsson et al., 1986). While still unproven 
(Chapman et al., 1982), it has been proposed that the 
increased brain GABA levels result in increased 
GABA release (Gram et al., 1988) and, therefore, an 
antiepileptic action. 
EFFECTS OF AEDs ON 
CALCIUM CURRENTS 
In addition to effects on sodium channels, clini- 
cally used AEDs have demonstrated effects on cal- 
cium channels (Macdonald and McLean, 1986). Cal- 
cium enters neurons through three different 
voltage-dependent calcium channels (Nowycky, et 
al., 1985), designated L, N, and T (Fig. 6). These 
calcium channels differ in their voltage dependency 
for activation and inactivation, rate of inactivation, 
and individual channel conductance. In addition, 
they have a different agonist and antagonist pharma- 
cology. L-channel conductance is large, and L-cur- 
rent is long-lasting and slowly inactivating. T-channel 
conductance is small, and T-currents are transient 
and inactivate rapidly. N-channel conductance is in- 
termediate in magnitude, and N-current inactivates 
at a rate between that of the T- and Lcurrents. 
PHT, barbiturates, and BZDs have been demon- 
strated to reduce calcium influx into synaptic termi- 
nals (Blaustein and Ector, 1975; Ondrusek et al., 
1979; Leslie et al., 1980; Ferrendelli and Daniels- 
McQueen, 1982) and to block presynaptic release of 
neurotransmitter (Somjen, 1963; Kalant and Grose, 
1967; Richter and Waller, 1977; Yarri et al., 1977; 
Mitchell and Martin, 1978) at supratherapeutic con- 
centrations. The barbiturates PB and pentobarbital 
block both L- and N-currents, without affecting T- 
calcium current, at anesthetic but not free-serum 
AED concentrations (Gross and Macdonald, 1987, 
1988) (Fig. 6). Similarly, PHT (McLean and Mac- 
donald, 1983) and DZP (Skemtt et al., 1984) have 
been demonstrated to block calcium currents at su- 
pratherapeutic AED concentrations. 
In contrast, ESM and the tnmethadione metabo- 
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lite, dimethadione, have recently been shown to af- 
fect T-calcium currents in thalamic neurons (Coulter 
et al., 1988) and in primary afferent neurons (Gross et 
al., 1989) at therapeutically relevant concentrations 
(Fig. 7) (Table 4). It has been proposed that T-cal- 
cium currents are important pacemaker currents in 
thalamic neurons and that these currents may be re- 
sponsible, in part, for the 3-Hz rhythm seen in the 
electroencephalogram of patients with generalized 
absence seizures (Coulter et al., 1988). Blockade of 
T-calcium currents by ESM or trimethadione, then, 
would disrupt the slow rhythmic firing of thalamic 
neurons as well as the spike and wave discharge. 
However, VPA and CZP did not alter T-calcium cur- 
rents in primary afferent neurons (Gross et al., 1989). 
Thus, it is possible that this effect on T-calcium cur- 
rents may underlie the effect of ESM and trimetha- 
dione on generalized absence seizures but not the ef- 
fect of VPA and the BZDs. 
SUMMARY 
AEDs can be divided mechanistically into at least 
three classes (Table 5 )  based on ability to black SRF 
by enhancing sodium-channel inactivation, to en- 
hance GABAergic inhibition, and to block slow, 
pacemaker-driven, repetitive firing by blocking T-cal- 
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FIG. 6. Pentobarbital and phenobarbrtal ' (PB) reduced N- and L- but not Tcalcium merits. whereas nifedipine selectively reduced 
Lcalcium cunent. T- , L- , and N/Lcurrents were evoked using different membraneholding potentials and depdarizing commands. A 
controlcunentwasobtainad(1)andtheeffectsof pentobarbital(A,. B1.C1), PB(A2, &.C2). andnifedipine(&,. &,,C3)wemdefenninedby 
applying the drugs locally to the neuron from a ghss micropipette. The current was then evoked again (2) and superimposed on the control 
current. A. None of the drugs altered Tcalcium anent. 8: Pentobarbital and PB. but not nifedipine, increased the rate of inactivation of 
primarily the Ncomponent of the N/L-calaum current. C Pentobarbital. PB, and nifedipine decreased Lcalciwn current. Recordings wem 
made from mouse dorsal root ganglion neurons grown in cdl culture. (From Gross and Macdonald, 1987.) 
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- e d  20 maec 
FIG. 7. Ethosuximide (ESM) reduced Tcaldum current. Vdtageclamp recordings were obtained from acutely dissociated rat nodose 
ganglion neurons using the whdecdl recording technique. The neurons were held at -90 mV, and depdarizing commands in 5 mV 
increments were applied from -60 to -35 mV. Under control conditions. this voltageclamp sequence evoked a series of T-calcium 
currents. In the presence of ESM, currents at each command were reduced in amplitude. (From Gross and Macdonald, unpublished.) 
but do not modify GABAergic synaptic transmission 
or T-calcium current (Type I AEDs). Drugs such as 
PB, VPA, and the BZDs have dual actions, enhancing 
GABAergic synaptic transmission and blocking SRF; 
however, they do not alter T-calcium current (Type I1 
AEDs). ESM and dimethadione, on the other hand, 
have no effect on either postsynaptic GABA re- 
sponses or SRF, but they block T-calcium currents 
(Type 111 AEDs). 
These results further suggest that the ability of a 
Type I AED to block generalized tonic-clonic seizures 
and some forms of partial seizures may correlate with 
the ability of the AED to block SRF. On the other 
TABLE 4. Eficacy against T-calcium currents 
h g  gCaT CONC R X  
gCaT = Tcalcium current conductance. 
CONC = concentrations above which the AEDs modify so- 
R. = Threshold free-serum therapeutic concentration of ESM, 
+ = Effective at slightly supratherapeutic concentrations 
Drug abbreviations as in Table I 
dium-channel function. 
which was effective against generalized absence seizures. 
(CONC). 
hand, the ability of a Type I1 AED to enhance GA- 
BAergic synaptic transmission may be one mecha- 
nism to block myoclonic seizures. Whether or not 
generalized absence seizures are blocked by enhance- 
ment of GABAergic inhibition is uncertain, but the 
possibility remains. Type 111 AEDs may be effective 
against generalized absence seizures in humans owing 
to their effect on T-calcium current. This mechanistic 
classification of AEDs must remain tentative at the 
present time, since the actions described have not 
been directly demonstrated to be antiepileptic in ex- 
perimental animals. Nonetheless, it is likely that cel- 
lular mechanisms such as those demonstrated in vitro 
TABLE 5. Eficacy ofAEDs against sodium channels 
(gNa), GABA-receptor channels (GABA). 
and T-calcium channels (gCaT) 
gNa GABA g Q T  
- - PHT i f  
? CBZ ++ - 
VPA ++ i/? - 
PB f + - 
CZP f ++ - 
i ESM - - 
gCaT = Tcalcium current conductance. 
gNa = sodium conductance. 
Efficacy patterns may correlate with drug actions against general- 
ized tonic-clonic and partial seizures, myoclonic seizures, and gen- 
eralized absence seizures. 
Drug abbreviations as in Table 1. 
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are important for antiepileptic efficacy. Further in- 
vestigation may lead to a classification of AEDs based 
on mechanistic rather than empirical bases. 
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